Fundz

Primrose Bio® has raised significant growth capital investment, led by Signet Healthcare Partners. This funding will support their expansion efforts.

PRIVATESep 22, 2026

Round Type

Venture

San DiegoBiotechnology

Investors

Signet Healthcare Partners

Description

Primrose Bio® has successfully closed a significant growth capital investment round. The investment was led by Signet Healthcare Partners. This funding will aid in the company's expansion initiatives and enhance its operational capabilities. The exact amount raised has not been disclosed.

Quick answer

Primrose Bio raised an undisclosed amount in a funding round, dated September 22, 2026. Investors: Signet Healthcare Partners. Primrose Bio is based in San Diego, California, United States.

How much did Primrose Bio raise?
Primrose Bio raised an undisclosed amount in a funding round on September 22, 2026.
Who invested in Primrose Bio?
Signet Healthcare Partners is named as investors in this round.
What does Primrose Bio do?
Primrose Bio is focused on developing and commercializing its integrated end-to-end technology platform for solving complex drug manufacturing and design challenges.
Where is Primrose Bio based and how big is it?
Primrose Bio is based in San Diego, California, United States. Fundz records about 40 employees.
Who are the decision-makers at Primrose Bio?
Fundz holds 3 contacts at Primrose Bio, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Primrose Bio that raised within 45 days of this round, from Fundz verified event records.

  • BioVie raised $4.7M (Post-IPO Equity) on November 6, 2026.
  • Alethio raised $90M (Series A) on November 5, 2026.
  • altM raised $10M (Series A) on November 5, 2026.
  • FluoRok raised $30M (Series A) on November 5, 2026.
  • T-Therapeutics raised $133M (Series B) on November 5, 2026.
  • Venomics AI raised $2.7M (Pre-Seed) on November 5, 2026.

Who to call at Primrose Bio, and when

A new round usually means Primrose Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Primrose Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Primrose Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Primrose Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Primrose Bio

Location

10790 ROSELLE STREET

San Diego, California, United States

About

Primrose Bio is focused on developing and commercializing its integrated end-to-end technology platform for solving complex drug manufacturing and design challenges. Primrose major offerings include Pfenex Expression Technology®: a proprietary production system used in six approved products with up to 20x higher yields and unparalleled success in making complex proteins; Prima RNApols™: improved enzymes for mRNA manufacturing; and PeliCRM197®: a commercially validated CRM197 carrier protein used for conjugate vaccines. Several of the world's leading pharmaceutical companies use Primrose's technologies, including Merck, Jazz Pharmaceuticals, Alvogen, Serum Institute of India, Arcellx, Arcturus and others.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Primrose Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsHelge Z., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Primrose Bio's next move

See what Strategic adds

Primrose Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.